OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dual silencing of tumor-intrinsic VISTA and CTLA-4 stimulates T-cell mediated immune responses and inhibits MCF7 breast cancer development
Negar Hosseinkhani, Nima Hemmat, Elham Baghbani, et al.
Gene (2023) Vol. 896, pp. 148043-148043
Closed Access | Times Cited: 7
Negar Hosseinkhani, Nima Hemmat, Elham Baghbani, et al.
Gene (2023) Vol. 896, pp. 148043-148043
Closed Access | Times Cited: 7
Showing 7 citing articles:
The VISTA/VSIG3/PSGL-1 axis: crosstalk between immune effector cells and cancer cells in invasive ductal breast carcinoma
Mateusz Olbromski, Monika Mrozowska, Aleksandra Piotrowska, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 8
Open Access | Times Cited: 3
Mateusz Olbromski, Monika Mrozowska, Aleksandra Piotrowska, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 8
Open Access | Times Cited: 3
Multi-omics combined to investigate potential druggable therapeutic targets for stroke: A systematic Mendelian randomization study and transcriptome verification
Yi‐Ming Shi, Le Bao, Yanling Li, et al.
Journal of Affective Disorders (2024) Vol. 366, pp. 196-209
Closed Access | Times Cited: 1
Yi‐Ming Shi, Le Bao, Yanling Li, et al.
Journal of Affective Disorders (2024) Vol. 366, pp. 196-209
Closed Access | Times Cited: 1
Revisiting immune checkpoint inhibitors: new strategies to enhance efficacy and reduce toxicity
Dianying Zhang, Jingjing Zhao, Yujing Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Dianying Zhang, Jingjing Zhao, Yujing Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
CTLA-4 silencing could promote anti-tumor effects in hepatocellular
Amirhossein Mardi, Mahsan Alizadeh, Amir Shahabaddin Abdolalizadeh, et al.
Medical Oncology (2024) Vol. 41, Iss. 8
Closed Access
Amirhossein Mardi, Mahsan Alizadeh, Amir Shahabaddin Abdolalizadeh, et al.
Medical Oncology (2024) Vol. 41, Iss. 8
Closed Access
Biomarkers to predict the benefits of immune‑checkpoint blockade‑based therapy in patients with malignant peritoneal mesothelioma (Review)
Chunhong Wang, Yan Zhao, Wanru Liang
Oncology Letters (2024) Vol. 28, Iss. 6
Open Access
Chunhong Wang, Yan Zhao, Wanru Liang
Oncology Letters (2024) Vol. 28, Iss. 6
Open Access
VISTA-mediated immune evasion in cancer
Raymond Zhang, Tae Kon Kim
Experimental & Molecular Medicine (2024)
Open Access
Raymond Zhang, Tae Kon Kim
Experimental & Molecular Medicine (2024)
Open Access
Docetaxel treatment together with CTLA-4 knockdown enhances reduction of cell viability and amplifies apoptosis stimulation of MCF-7 breast cancer cells
Negar Hosseinkhani, Shiva Alipour, Amir Ghaffari Jolfayi, et al.
Cytotechnology (2024) Vol. 77, Iss. 1
Closed Access
Negar Hosseinkhani, Shiva Alipour, Amir Ghaffari Jolfayi, et al.
Cytotechnology (2024) Vol. 77, Iss. 1
Closed Access
